Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


Articles published in Clin Cancer Res

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    September 2018
  1. SEILER R, Gibb EA, Wang NQ, Oo HZ, et al
    Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Clin Cancer Res. 2018 Sep 17. pii: 1078-0432.CCR-18-1106.
    PubMed     Text format     Abstract available


    August 2018
  2. RAJA R, Kuziora M, Brohawn P, Higgs BW, et al
    Early reduction in ctDNA predicts survival in lung and bladder cancer patients treated with durvalumab.
    Clin Cancer Res. 2018 Aug 9. pii: 1078-0432.CCR-18-0386.
    PubMed     Text format     Abstract available


    July 2018
  3. BIELLI P, Panzeri V, Lattanzio R, Mutascio S, et al
    The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle invasive bladder cancer.
    Clin Cancer Res. 2018 Jul 16. pii: 1078-0432.CCR-17-3850.
    PubMed     Text format     Abstract available


  4. LI Q, Damish A, Frazier ZJ, Liu D, et al
    ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Jul 6. pii: 1078-0432.CCR-18-1001.
    PubMed     Text format     Abstract available


    June 2018
  5. LELO A, Prip F, Harris BT, Solomon D, et al
    STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Jun 28. pii: 1078-0432.CCR-17-3244.
    PubMed     Text format     Abstract available


    March 2018
  6. FU H, Zhu Y, Wang Y, Liu Z, et al
    Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Mar 7. pii: 1078-0432.CCR-17-2687.
    PubMed     Text format     Abstract available


    January 2018
  7. VAN KESSEL KE, van der Keur KA, Dyrskjot L, Algaba F, et al
    Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups.
    Clin Cancer Res. 2018 Jan 24. pii: 1078-0432.CCR-17-2719.
    PubMed     Text format     Abstract available


    December 2017
  8. CHEN CH, Changou C, Hsieh TH, Lee YC, et al
    Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer.
    Clin Cancer Res. 2017 Dec 8. pii: 1078-0432.CCR-17-2066.
    PubMed     Text format     Abstract available


    September 2017
  9. MARTINEZ VG, Rubio C, Martinez-Fernandez M, Segovia C, et al
    BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer.
    Clin Cancer Res. 2017 Sep 19. pii: clincanres.1004.2017.
    PubMed     Text format     Abstract available


  10. WU S, Zheng J, Li Y, Yu H, et al
    A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.
    Clin Cancer Res. 2017 Sep 5. pii: clincanres.1510.2017.
    PubMed     Text format     Abstract available


    August 2017
  11. KATES M, Date A, Yoshida T, Afzal U, et al
    Preclincial Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.1082.2017.
    PubMed     Text format     Abstract available


  12. ZENG S, Zhu Y, Ma AH, Yu W, et al
    The Phosphatidylinositol 3-kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.0033.2017.
    PubMed     Text format     Abstract available


  13. WEN T, Yang Z, He L, Lin K, et al
    The KMT1A-GATA3-STAT3 circuit is a novel self-renewal signaling of human bladder cancer stem cells.
    Clin Cancer Res. 2017 Aug 1. pii: clincanres.0882.2017.
    PubMed     Text format     Abstract available


    July 2017
  14. VANDEKERKHOVE GR, Todenhofer T, Annala M, Struss WJ, et al
    <span style="font-weight: 400;">Circulating tumor DNA reveals clinically-actionable somatic genome of metastatic bladder cancer</span>.
    Clin Cancer Res. 2017 Jul 31. pii: clincanres.1140.2017.
    PubMed     Text format     Abstract available


    April 2017
  15. YANG L, Taylor J, Eustace A, Irlam J, et al
    A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High Risk Bladder Cancer Patients.
    Clin Cancer Res. 2017 Apr 11. pii: clincanres.0038.2017.
    PubMed     Text format     Abstract available


    February 2017
  16. SIN ML, Mach KE, Sinha R, Wu F, et al
    Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics.
    Clin Cancer Res. 2017 Feb 13. pii: clincanres.2610.2016.
    PubMed     Text format     Abstract available


    January 2017
  17. WANG WJ, Li CF, Chu YY, Wang YH, et al
    Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
    Clin Cancer Res. 2017;23:503-513.
    PubMed     Text format     Abstract available


    November 2016
  18. INMAN BA, Longo TA, Ramalingam S, Harrison MR, et al
    Atezolizumab: a PD-L1 blocking antibody for bladder cancer.
    Clin Cancer Res. 2016 Nov 30. pii: clincanres.1417.2016.
    PubMed     Text format     Abstract available


    March 2016
  19. GUIN S, Ru Y, Agarwal N, Lew CR, et al
    Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
    Clin Cancer Res. 2016;22:1274-83.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: